Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ventricular tachycardia complicating alcohol septal ablation.

Literature DB >> 15509832

Ventricular tachycardia complicating alcohol septal ablation.

Chester M Boltwood, Walter Chien, Thomas Ports.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Ethanol

Year: 2004 PMID： 15509832 DOI： 10.1056/NEJM200410283511824

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

Review 1. Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors: Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal: Cochrane Database Syst Rev Date: 2012-05-16

2. Increasing evidence for the safety and efficacy of alcohol septal ablation during medium- and long-term follow-up.

Authors: M Pauschinger; A Keren
Journal: Clin Res Cardiol Date: 2007-11-05 Impact factor: 5.460

Review 3. Contemporary treatment of hypertrophic cardiomyopathy.

Authors: Ali J Marian
Journal: Tex Heart Inst J Date: 2009

4. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.

Authors: Angelos G Rigopoulos; Silke Daci; Barbara Pfeiffer; Konstadia Papadopoulou; Anna Neugebauer; Hubert Seggewiss
Journal: Clin Res Cardiol Date: 2016-06-06 Impact factor: 5.460

Review 5. Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.

Authors: Georgios K Efthimiadis; Efstathios D Pagourelias; Thomas Gossios; Thomas Zegkos
Journal: World J Cardiol Date: 2014-02-26

6. The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.

Authors: Mariusz Klopotowski; Lidia Chojnowska; Lukasz A Malek; Renata Maczynska; Krzysztof Kukula; Marcin Demkow; Adam Witkowski; Maciej Dabrowski; Maciej Karcz; Rafal Baranowski; Beata Kusmierczyk-Droszcz; Mariusz Kruk; Jacek Jamiolkowski; Mariusz Kusmierczyk; Lukasz Szumowski; Witold Ruzyllo
Journal: Clin Res Cardiol Date: 2010-02-11 Impact factor: 5.460

Ventricular tachycardia complicating alcohol septal ablation.

Review 1. Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

2. Increasing evidence for the safety and efficacy of alcohol septal ablation during medium- and long-term follow-up.

Review 3. Contemporary treatment of hypertrophic cardiomyopathy.

4. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.

Review 5. Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.

6. The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.

Review 7. Experimental therapies in hypertrophic cardiomyopathy.

Review 8. Sudden death in hypertrophic cardiomyopathy.

9. A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy.

10. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.